References
CAHLÍKOVÁ, L., KAWANO, I., ŘEZÁČOVÁ, M., BLUNDEN, G., HULCOVÁ, D., HAVELEK, R. The Amaryllidaceae alkaloids haemanthamine, haemanthidine and their semisynthetic derivatives as potential drugs. Phytochemistry Reviews 2021, 20(1), 303-323. DOI: 10.1007/s11101-020-09675-8
PELLEGRINO, S., MEYER, M., ZORBAS, C. et al. The Amaryllidaceae Alkaloid Haemanthamine Binds the Eukaryotic Ribosome to Repress Cancer Cell Growth. Structure 2018, 26(3), 416-425.e4. DOI: 10.1016/j.str.2018.01.009
PEŘINOVÁ, R., MAAFI, M., KORÁBEČNÝ, J., KOHELOVÁ, E., DE SIMONE, A., AL MAMUN, A., HULCOVÁ, D.,MARKOVÁ, J., KUČERA, T., JUN, D., ŠAFRATOVÁ, M., MAŘÍKOVÁ, J., ANDRISANO, V., JENČO, J., KUNEŠ, J., MARTINEZ, A., NOVÁKOVÁ, L., CAHLÍKOVÁ, L. Functionalized aromatic esters of the Amaryllidaceae alkaloid haemanthamine and their in vitro and in silico biological activity connected to Alzheimer´s disease. Bioorganic Chemistry 2020, 100, 103928. DOI: 10.1016/j.bioorg.2020.103928
EVIDENTE, A., KIREEV, A., JENKINS, A., ROMERO, A., STEELANT, W., VAN SLAMBROUCK, S., KORNIENKO, A. Biological Evaluation of Structurally Diverse Amaryllidaceae Alkaloids and their Synthetic Derivatives: Discovery of Novel Leads for Anticancer Drug Design. Planta Medica 2009, 75(05), 501-507. DOI: 10.1055/s-0029-1185340
